The report "Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021", Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the urinalysis market along with the estimates and forecasts of the revenue and market share analysis.

Browse 278 market data Tables and 41 Figures spread through 223 Pages and in-depth TOC on "Urinalysis Market”.

http://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html

Early buyers will receive 10% customization on reports.

The global Urinalysis market is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in 2016 at a CAGR of 7.6% from 2016 to 2021.

Growth Factors:
The major factors driving the growth of this market are rising prevalence of kidney diseases and urinary tract infections, implementation of PPACA, technological advancements, increasing adoption rate of point-of-care urinalysis devices, increasing healthcare expenditure and increasing geriatric population.

The reporting segments in this market include product type, test type, applications, and end user. On the basis of product type, the urinalysis market is segmented into consumables and instruments. Consumables are expected to account for the largest share of the market due to factors such as wide use of disposables in urinalysis testing and research, the introduction of new and advanced reagents & dipsticks and the utilization of disposables at a larger scale in the market.

On the basis of test type, the urinalysis market is segmented into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis segment is expected to account for the largest share of the global urinalysis market in 2016. The rapidly growing geriatric population and rising prevalence of kidney diseases and urinary tract infections are the key factors propelling the growth of this market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=153479294

On the basis of end user, the urinalysis market includes hospitals and clinical laboratories, diagnostics laboratory, research laboratories and institutes and home care settings. The hospitals and clinical laboratories segment is expected to account for the largest share of the global urinalysis market in 2016. Extensive use of dipsticks by hospitals and clinical laboratories is the major factors driving the growth of this market.

Based on applications, the global urinalysis market is segmented into disease diagnostics and pregnancy tests. Disease diagnostics segment is expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by the factors such as advancement in the development of new urinalysis tests for better and early diagnosis of chronic diseases.

Geographically:
Based on geography, the global urinalysis market is segmented into North America, Europe, Asia and Row. Asia segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is driven by the factors such as rising demand for urine testing products, increasing healthcare expenditure, rising prevalence of diabetes, and growing geriatric population are driving the growth of the urinalysis market in this region.
The key players in the urinalysis market include Beckman Coulter (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Sysmex Corporation (Japan) and ARKRAY, Inc. (Japan).

Request Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=153479294

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
E-mail: [email protected]
Tel: 1-888-600-6441